Loading
Total declarations
Companies
▲ Purchases (9 ops.)
▼ Sales (4 ops.)
Latest filing published 13 Oct 2026 for Retension Pharmaceuticals, Inc.. Read the official filing
Filing timeline
BuySaleFranklin M. Berger
Insider track record
Disclosed buys
9
Disclosed sells
4
Signal history
Closed purchases
Market purchases
9
Positive at T+90
0%
Median T+90
-39.1%
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +6.2%Entry US$3.24 · Close at T+365 US$3.44
- -81.5%Entry US$180.60 · Close at T+365 US$33.50
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Franklin M. Berger: trading record in brief
Filings by Franklin M. Berger span 5 companies, the busiest being Atea Pharmaceuticals, Inc., ESSA Pharma Inc. and Rain Therapeutics Inc. The record holds 20 filings, for trades running from 21 September 2021 to 13 October 2026.
Both buying and selling appear: 9 purchases worth €1.5M, against 4 sales worth €1.2M. The net balance comes to €227k on the buying side. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 4 option exercises. So far in 2026, the count stands at 1 purchase and no sales.
Half of the purchases are above €122k and half below. On 4 out of 8 purchases, another insider of the same company was buying within the same 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.
Most recently, on 13 October 2026, the filings show a transaction in Retension Pharmaceuticals, Inc. The last purchase on record was published on 13 October 2026, which is 5 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Franklin M. Berger
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations19 total
12,517 sharesCommon StockSEC:0001213900-26-109155:0
10,000 shares@ US$12.00Common StockSEC:0001213900-26-109155:1
Canonical exit: 11 Jan 2027 (T+90)
29,600 sharesCommon StockSEC:0001193125-26-279726:0
784,404 sharesCommon SharesSEC:0001104659-25-099655:0
29,600 shares0Common StockSEC:0000950170-25-089606:0
15,000 shares@ US$3.19233.8% of flowCommon StockSEC:0000950170-25-006489:0
Canonical exit: 15 Apr 2025 (T+90)
359,606 shares@ US$2.846179.1% of flowCommon StockSEC:0000950170-24-135930:0
33,150 shares0Common StockSEC:0000950170-24-074987:0
1,005,207 sharesCommon Stock, par value $0.001 per shareSEC:0001999371-24-000962:0
23,259 shares@ US$5.7324.6% of flowCommon SharesSEC:0000950170-23-065921:0
Canonical exit: 19 Feb 2024 (T+90)
60,000 shares@ US$5.3561.2% of flowCommon StockSEC:0000950170-23-064584:0
Canonical exit: 31 Jan 2024 (T+90)
25,000 shares@ US$3.0014.2% of flowCommon SharesSEC:0000899243-23-000914:0
45,000 shares@ US$7.8053.5% of flowCommon StockSEC:0001104659-22-121849:0
Canonical exit: 19 Feb 2023 (T+90)
25,500 shares@ US$5.150310.5% of flowCommon StockSEC:0000899243-22-035942:0
16,166 shares@ US$5.1566.6% of flowCommon StockSEC:0000899243-22-035942:1
42,881 shares@ US$5.8339.3% of flowCommon StockSEC:0000899243-22-035691:0
Canonical exit: 6 Feb 2023 (T+90)
15,000 shares@ US$15.9682.8% of flowCommon StockSEC:0001209191-22-020584:0
Canonical exit: 16 Jun 2022 (T+90)
8,896 shares@ US$5.9117.2% of flowCommon StockSEC:0001209191-21-057418:0
3,786 shares@ US$14.307.3% of flowCommon StockSEC:0000899243-21-037351:0
Canonical exit: 20 Dec 2021 (T+90)
19 of 19 declarations
